Digital Consults to Enhance Heart Failure Treatment: The ADMINISTER Trial
Cardiology Update
AUGUST 4, 2024
This includes beta-blockers, ACE inhibitors, ARBs, ARNIs, MRAs, and SGLT2 inhibitors. The primary outcome is the GDMT prescription rate score, with secondary outcomes covering the time to full GDMT optimization, patient and clinician satisfaction, time spent on healthcare, and the Kansas City Cardiomyopathy Questionnaire.
Let's personalize your content